Trade Groups Encouraged By NIH Plans For Phase III Creatine Trial
This article was originally published in The Tan Sheet
Executive Summary
Supplement trade associations are optimistic about the March 22 launch of a NIH-funded large-scale clinical trial on creatine and Parkinson's disease because of existing scientific evidence supporting the ingredient's positive effects on neuromuscular disorders